Scientists track immune cells to learn why cancer treatments work
NCT ID NCT02978118
Summary
This study aims to learn how the immune system changes when patients with advanced kidney or bladder cancer receive immunotherapy drugs. Researchers will collect blood samples from about 67 patients before and during treatment to measure different immune cells and cancer cells in the blood. The goal is to gather information that might help predict which patients will respond best to these treatments in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, RENAL CELL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
Conditions
Explore the condition pages connected to this study.